Abstract
US president Donald J. Trump is ordering federal agencies to slash the number of advisory committees they depend on for counsel, including for science expertise. In a June 14 executive order, Trump directed each agency to eliminate by Sept. 30 at least a third of its federal advisory committees that were not established by Congress in federal laws. Trump also called for the termination of committees that Congress created but “whose continued operations no longer serve the public interest.” The order carves out two notable exceptions. Panels that approve extramural research grants or cooperative agreements for agencies such as the National Institutes of Health will remain. Also left to stand are committees that “provide scientific expertise to support agencies making decisions related to the safety or efficacy of products to be marketed to American consumers.” This would likely apply to the US Food and Drug Administration’s pharmaceutical advisory committees and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
